Surgical Innovations Group (SUN)

Sector:

Health Care

Index:

FTSE AIM All-Share

0.80p
   
  • Change Today:
      0.15p
  • 52 Week High: 1.80
  • 52 Week Low: 0.40
  • Currency: UK Pounds
  • Shares Issued: 932.82m
  • Volume: 6,492,422
  • Market Cap: £7.46m
  • RiskGrade: 341

SUN Overview

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for use in minimally invasive surgery (MIS) and industrial markets. Our Strategy is to develop the OEM proposition to provide a full-service solution from concept, through to the development and manufacture of innovative devices.

1 Day Chart (26-07-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -5.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.5 0.5
Pr/Book 0.6  
Latest F'cast
Revenue 5.9% 3.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SUN Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 10.73 (2.60) (0.33)p n/a n/a n/a n/a 0.0%
31-Dec-20 6.33 (3.31) (0.33)p n/a n/a n/a n/a 0.0%
31-Dec-21 9.13 (0.58) (0.02)p n/a n/a n/a n/a 0.0%
31-Dec-22 11.34 (0.06) 0.03p 53.3 n/a n/a n/a 0.0%
31-Dec-23 12.01 (0.73) (0.06)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SUN Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 12.40 n/a (0.03)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

SUN Company Announcements

Holding(s) in Company 25-Jul-2024 16:04 RNS
Result of AGM 17-Jun-2024 16:43 RNS
Directorate Change - Appointment of CFO 10-Jun-2024 07:00 RNS

Latest SUN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SUN Market Data

Currency UK Pounds
Share Price 0.80p
Change Today 0.15p
% Change 23.08 %
52 Week High 1.80
52 Week Low 0.40
Volume 6,492,422
Shares Issued 932.82m
Market Cap £7.46m
RiskGrade 341

SUN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.33% above the market average58.33% above the market average58.33% above the market average58.33% above the market average58.33% above the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average
Price Trend
50.65% below the market average50.65% below the market average50.65% below the market average50.65% below the market average50.65% below the market average
8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average
Income Not Available
Growth
10.02% above the market average10.02% above the market average10.02% above the market average10.02% above the market average10.02% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SUN Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
16:02 50,000 @ 0.85p
15:44 450,000 @ 0.79p
14:41 150,000 @ 0.78p
14:26 600,000 @ 0.78p
13:21 46,865 @ 0.78p

SUN Key Personnel

CEO David Marsh
Chair Jonathan Glenn

Top of Page